Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 40
Acute Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 42
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 ...
Published: May 2022 - Pages: 49
Adenocarcinoma Of The Gastroesophageal Junction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key ...
Published: May 2022 - Pages: 250
Adenoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 57
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Ant...
Published: May 2022 - Pages: 124
Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 97
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) Drugs in Development by...
Published: May 2022 - Pages: 113
Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 43
Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 112
Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 64
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA...
Published: May 2022 - Pages: 55
Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 52
Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 41
Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 36
Bacillus Anthracis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 71
Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 134
Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 75
Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 61
Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 43
